617 filings
Page 4 of 31
8-K
wspm6592lu1
9 Nov 20
Other Events
5:25pm
424B5
57zb74g4bryvw9i
9 Nov 20
Prospectus supplement for primary offering
5:13pm
8-K
tcv5 8n4bm
4 Nov 20
TG Therapeutics Highlights Data Selected for Presentation at the 62nd American Society of Hematology (ASH) Annual Meeting
8:50pm
8-K
2pt4zqin6ous40s06zo
10 Aug 20
TG Therapeutics Provides Business Update and Reports Second Quarter 2020 Financial Results
7:30am
8-K
olg0mgslpj9
24 Jun 20
Departure of Directors or Certain Officers
5:00pm
PX14A6G
uepnt1
29 May 20
Letter to shareholders
11:16am
8-K
e1ryb
18 May 20
Entry into a Material Definitive Agreement
5:00pm
424B5
pd3xle8 ohv2l3n
18 May 20
Prospectus supplement for primary offering
4:02pm
424B5
ttffzlpsplol7j4rshqu
14 May 20
Prospectus supplement for primary offering
5:18pm
8-K
mudp mxxwoy4ugj7mp
11 May 20
TG Therapeutics Provides Business Update and Reports First Quarter 2020 Financial Results
5:16pm
8-K
bon 3cjyvpr4q6qio7n
5 May 20
Other Events
7:30am
8-K
okm l75ybnaz
30 Apr 20
TG Therapeutics Bolsters Board of Directors with the Appointment of Sagar Lonial, MD
7:31am
DEFA14A
gv0ocf27
29 Apr 20
Additional proxy soliciting materials
4:32pm
424B5
bg4ccboa1zn7zg9mzx
20 Mar 20
Prospectus supplement for primary offering
4:54pm
8-K
zz4 i8cmdad3
20 Mar 20
Other Events
4:39pm
8-K
z07qxs1
3 Mar 20
TG Therapeutics Provides Business Update and Reports Fourth Quarter and Year-End 2019 Financial Results
7:22am